Basics |
Bionano Genomics, Inc.
|
IPO Date: |
September 21, 2018 |
Sector: |
Healthcare |
Industry: |
Diagnostics and Research |
Market Cap: |
$12.13M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.13 | 4.62%
|
Avg Daily Range (30 D): |
$0.18 | 4.95%
|
Avg Daily Range (90 D): |
$0.18 | 5.28%
|
Institutional Daily Volume |
Avg Daily Volume: |
8.65M |
Avg Daily Volume (30 D): |
.16M |
Avg Daily Volume (90 D): |
2.18M |
Trade Size |
Avg Trade Size (Sh.): |
378 |
Avg Trade Size (Sh.) (30 D): |
136 |
Avg Trade Size (Sh.) (90 D): |
645 |
Institutional Trades |
Total Inst.Trades: |
870 |
Avg Inst. Trade: |
$1.76M |
Avg Inst. Trade (30 D): |
$.7M |
Avg Inst. Trade (90 D): |
$.7M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$2.59M |
Avg Closing Trade (30 D): |
$.7M |
Avg Closing Trade (90 D): |
$.7M |
Avg Closing Volume: |
.98K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-88.73
|
$-1.15
|
|
Diluted EPS
|
$-88.73
|
$-1.15
|
|
Revenue
|
$ 28.46M
|
$ 6.46M
|
$
|
Gross Profit
|
$ .5M
|
$ 2.94M
|
$
|
Net Income / Loss
|
$ -83.7M
|
$ -3.1M
|
$
|
Operating Income / Loss
|
$ -81.33M
|
$ -8.47M
|
$
|
Cost of Revenue
|
$ 27.97M
|
$ 3.52M
|
$
|
Net Cash Flow
|
$ -12.53M
|
$ -5.95M
|
$
|
PE Ratio
|
|
|
|
Splits |
Jan 27, 2025:
60:1
|
Aug 07, 2023:
10:1
|
|